DBT Bureau
Pune, 29 Nov 2025
Since November 7, 2025, Divi’s Laboratories has seen a period of mild downward pressure despite strong quarterly results. The stock closed at ₹6,656.50 on November 7, but over the following two weeks, it gradually softened, trading between ₹6,500–₹6,600 before slipping further. By November 24, 2025, the stock closed at ₹6,377.45, marking a decline of about 4.2% from the November 7 level. This movement came even as the company reported a 35% year-on-year rise in Q2 profit and 16% growth in revenue, suggesting that broader market sentiment, profit-booking, and sector-wide pressures weighed on the stock. Despite the short-term dip, Divi’s Laboratories continues to trade comfortably within its 52-week range and remains a resilient performer backed by strong fundamentals and consistent long-term growth.
Divi’s Laboratories — Recent stock performance
| Date | Closing Price (₹) |
|---|---|
| 07-Nov-2025 | 6,656.50 |
| 10-Nov-2025 | 6,691.50 |
| 11-Nov-2025 | 6,539.50 |
| 12-Nov-2025 | 6,520.00 |
| 13-Nov-2025 | 6,593.50 |
| 14-Nov-2025 | 6,511.50 |
| 24-Nov-2025 | 6,322.00 |
Standalone Financial Results (₹ in crores)
| Particulars | For the Quarter Ended 30-09-2025 | For the Quarter Ended 30-09-2024 | For the Half Year Ended 30-09-2025 | For the Half Year Ended 30-09-2024 |
|---|---|---|---|---|
| Total Income | 2806 | 2407 | 5282 | 4548 |
| PBT | 920 | 735 | 1667 | 1338 |
| Tax Expense | 224 | 217 | 414 | 390 |
| PAT | 696 | 518 | 1253 | 948 |
Forex Gain / (Loss) (₹ in crores)
| Particulars | For the Quarter Ended 30-09-2025 | For the Quarter Ended 30-09-2024 | For the Half Year Ended 30-09-2025 | For the Half Year Ended 30-09-2024 |
|---|---|---|---|---|
| Forex Gain | 64 | 27 | 103 | 26 |
